Physician profile
Gregory Lekovic
NPI 1770763740
$1,398.49
in general payments reported to CMS, 2019-2025
13 companies · $375 in 2025
The $375 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2021: $275 · 2022: $327 · 2024: $78.71 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370 · Travel and Lodging: $84.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.61 |
| Travel and Lodging | $84.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microtransponder, INC. | $194.06 | 2022 | |
| Globus Medical, INC. | $165.02 | 2024-2025 | Excelsius Gps, Mars Acdf Retractor |
| Medtronic, INC. | $154.52 | 2021 | |
| Intersect Ent, INC. | $148.74 | 2019 | |
| Penumbra, INC. | $133.35 | 2022 | |
| Medical Device Business Services, INC. | $124.52 | 2025 | Matrixneuro |
| Nuvasive, INC. | $120.46 | 2021 | |
| Monteris Medical Corporation | $118.66 | 2025 | Neuroblate |
| Carl Zeiss Meditec, INC. | $94.67 | 2019 | |
| Zimmer Biomet Holdings, INC. | $69.00 | 2019 | |
| Genzyme Corporation | $30.51 | 2024 | |
| Karl Storz Endoscopy-America | $29.52 | 2019 | |
| Incyte Corporation | $15.46 | 2024 | Monjuvi, Pemazyre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Lekovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.